{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:44:52Z","timestamp":1790502292768,"version":"4.1.0"},"reference-count":55,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"unspecified","delay-in-days":296,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2019]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Conditions and evidence continue to evolve related to the prediction of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters, which affect assumptions related to forecasting risks and evaluating potential risk management options. Multiple recent reviews provided information about individual iVDPV excreters, but inconsistencies among the reviews raise some challenges. This analysis revisits the available evidence related to iVDPV excreters and provides updated model estimates that can support future risk management decisions. The results suggest that the prevalence of iVDPV excreters remains highly uncertain and variable, but generally confirms the importance of managing the risks associated with iVDPV excreters throughout the polio endgame in the context of successful cessation of all oral poliovirus vaccine use.<\/jats:p>","DOI":"10.1017\/s095026881900181x","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T15:21:22Z","timestamp":1571930482000},"source":"Crossref","is-referenced-by-count":28,"title":["Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters"],"prefix":"10.1017","volume":"147","author":[{"given":"D. A.","family":"Kalkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0849-9147","authenticated-orcid":false,"given":"K. M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"S095026881900181X_ref55","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1635463"},{"key":"S095026881900181X_ref54","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1506333"},{"key":"S095026881900181X_ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.03.037"},{"key":"S095026881900181X_ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3074-0"},{"key":"S095026881900181X_ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01103"},{"key":"S095026881900181X_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2006.02.005"},{"key":"S095026881900181X_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.01.018"},{"key":"S095026881900181X_ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1115-5"},{"key":"S095026881900181X_ref36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu043"},{"key":"S095026881900181X_ref17","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268816002302"},{"key":"S095026881900181X_ref50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-124545"},{"key":"S095026881900181X_ref12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.7.3001-3010.2000"},{"key":"S095026881900181X_ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1981.tb00095.x"},{"key":"S095026881900181X_ref5","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12022"},{"key":"S095026881900181X_ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1112-8"},{"key":"S095026881900181X_ref6","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit845"},{"key":"S095026881900181X_ref2","unstructured":"World Health Organization Global Polio Eradication Initiative (2013) Polio eradication and endgame Strategic Plan (2013\u20132018). Available at http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf (Accessed 4 June 2019)."},{"key":"S095026881900181X_ref3","unstructured":"World Health Organization Global Polio Eradication Initiative (2015) Polio eradication & endgame: Midterm review July 2015. Available at http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/GPEI-MTR_July2015.pdf (Accessed 4 June 2019)."},{"key":"S095026881900181X_ref48","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.28.4.986"},{"key":"S095026881900181X_ref40","first-page":"208","article-title":"Pediatric patients with common variable immunodeficiency: long-term follow-up","volume":"22","author":"Mohammadinejad","year":"2012","journal-title":"Journal of Investigational Allergology and Clinical Immunology"},{"key":"S095026881900181X_ref1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6535a3"},{"key":"S095026881900181X_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-385991-4.00002-7"},{"key":"S095026881900181X_ref15","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/JCM.36.10.2893-2899.1998","article-title":"Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient","volume":"36","author":"Kew","year":"1998","journal-title":"Journal of Clinical Microbiology"},{"key":"S095026881900181X_ref21","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu295"},{"key":"S095026881900181X_ref51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01567"},{"key":"S095026881900181X_ref47","unstructured":"World Bank (2019) World Bank list of economies (June 2019). Available at http:\/\/databank.worldbank.org\/data\/download\/site-content\/CLASS.xls (Accessed 17 July 2019)."},{"key":"S095026881900181X_ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00827.x"},{"key":"S095026881900181X_ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1536-9"},{"key":"S095026881900181X_ref9","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12031"},{"key":"S095026881900181X_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.01.015"},{"key":"S095026881900181X_ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2012.01864.x"},{"key":"S095026881900181X_ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066849"},{"key":"S095026881900181X_ref30","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.864563"},{"key":"S095026881900181X_ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1077"},{"key":"S095026881900181X_ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00844.x"},{"key":"S095026881900181X_ref26","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01174-13"},{"key":"S095026881900181X_ref27","first-page":"pii\/19566","article-title":"Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage","volume":"15","author":"Roivainen","year":"2010","journal-title":"Euro Surveillance"},{"key":"S095026881900181X_ref24","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881000316X"},{"key":"S095026881900181X_ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-011-8241-y"},{"key":"S095026881900181X_ref31","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2013.18.38.20586"},{"key":"S095026881900181X_ref53","unstructured":"Global Polio Eradication Initiative (2018) Global Wild Poliovirus 2013\u20132018. Available at http:\/\/polioeradication.org\/wp-content\/uploads\/2018\/12\/global-wild-poliovirus-2013-2018-20181204.pdf (Accessed 4 June 2019)."},{"key":"S095026881900181X_ref11","first-page":"72","article-title":"Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia","volume":"310","author":"MacCallum","year":"1971","journal-title":"Special report series (Medical Research Council (Great Britain))"},{"key":"S095026881900181X_ref32","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu674"},{"key":"S095026881900181X_ref35","volume-title":"Exploring the Role of Antiviral Drugs in the Eradication of Polio: Workshop Report","year":"2006"},{"key":"S095026881900181X_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.059"},{"key":"S095026881900181X_ref37","first-page":"335","article-title":"Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model","volume":"215","author":"Collett","year":"2017","journal-title":"Journal of Infectious Diseases"},{"key":"S095026881900181X_ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1537-8"},{"key":"S095026881900181X_ref38","first-page":"3","article-title":"Search for polio virus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil and the United Kingdom","volume":"82","author":"Halsey","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"S095026881900181X_ref10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.Supplement_1.S176"},{"key":"S095026881900181X_ref39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03954.x"},{"key":"S095026881900181X_ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8498-z"},{"key":"S095026881900181X_ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8784-z"},{"key":"S095026881900181X_ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-8996-5"},{"key":"S095026881900181X_ref45","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6643a6"},{"key":"S095026881900181X_ref46","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6742a5"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S095026881900181X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:35:57Z","timestamp":1611621357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S095026881900181X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":55,"alternative-id":["S095026881900181X"],"URL":"https:\/\/doi.org\/10.1017\/s095026881900181x","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"e295"}}